nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—SLC6A4—conduct disorder	0.475	0.565	CbGaD
Doxepin—HTR2A—conduct disorder	0.365	0.435	CbGaD
Doxepin—ORM1—saliva—conduct disorder	0.00707	0.237	CbGeAlD
Doxepin—SLC6A2—autonomic nervous system—conduct disorder	0.00542	0.182	CbGeAlD
Doxepin—HTR2A—autonomic nervous system—conduct disorder	0.00326	0.109	CbGeAlD
Doxepin—CHRM4—brain—conduct disorder	0.00122	0.0408	CbGeAlD
Doxepin—HTR6—brain—conduct disorder	0.00109	0.0365	CbGeAlD
Doxepin—HRH2—brain—conduct disorder	0.000994	0.0333	CbGeAlD
Doxepin—CHRM5—brain—conduct disorder	0.00095	0.0319	CbGeAlD
Doxepin—ADRA1B—brain—conduct disorder	0.000868	0.0291	CbGeAlD
Doxepin—ADRA1D—brain—conduct disorder	0.000849	0.0285	CbGeAlD
Doxepin—CHRM2—brain—conduct disorder	0.000652	0.0219	CbGeAlD
Doxepin—Cyclobenzaprine—HTR2A—conduct disorder	0.000642	0.0993	CrCbGaD
Doxepin—HTR2C—brain—conduct disorder	0.000628	0.0211	CbGeAlD
Doxepin—SLC6A4—brain—conduct disorder	0.000596	0.02	CbGeAlD
Doxepin—CHRM1—brain—conduct disorder	0.000593	0.0199	CbGeAlD
Doxepin—HTR2B—brain—conduct disorder	0.00059	0.0198	CbGeAlD
Doxepin—Promazine—DRD4—conduct disorder	0.00057	0.0882	CrCbGaD
Doxepin—CHRM3—brain—conduct disorder	0.000531	0.0178	CbGeAlD
Doxepin—HTR1A—brain—conduct disorder	0.000529	0.0177	CbGeAlD
Doxepin—SLC6A2—brain—conduct disorder	0.000524	0.0176	CbGeAlD
Doxepin—ADRA1A—brain—conduct disorder	0.000488	0.0164	CbGeAlD
Doxepin—DRD2—brain—conduct disorder	0.000478	0.016	CbGeAlD
Doxepin—KCNH2—brain—conduct disorder	0.000471	0.0158	CbGeAlD
Doxepin—ADRA2C—brain—conduct disorder	0.000465	0.0156	CbGeAlD
Doxepin—Clomipramine—SLC6A4—conduct disorder	0.000439	0.0679	CrCbGaD
Doxepin—Nortriptyline—SLC6A4—conduct disorder	0.000429	0.0663	CrCbGaD
Doxepin—Thiothixene—HTR2A—conduct disorder	0.000427	0.066	CrCbGaD
Doxepin—Trimipramine—SLC6A4—conduct disorder	0.000404	0.0625	CrCbGaD
Doxepin—HRH1—brain—conduct disorder	0.000377	0.0127	CbGeAlD
Doxepin—ADRA2A—brain—conduct disorder	0.000371	0.0124	CbGeAlD
Doxepin—Desipramine—SLC6A4—conduct disorder	0.000353	0.0546	CrCbGaD
Doxepin—Clomipramine—HTR2A—conduct disorder	0.000337	0.0522	CrCbGaD
Doxepin—Chlorprothixene—HTR2A—conduct disorder	0.000336	0.0519	CrCbGaD
Doxepin—Nortriptyline—HTR2A—conduct disorder	0.00033	0.051	CrCbGaD
Doxepin—HTR2A—brain—conduct disorder	0.000315	0.0106	CbGeAlD
Doxepin—Trimipramine—HTR2A—conduct disorder	0.000311	0.048	CrCbGaD
Doxepin—Imipramine—SLC6A4—conduct disorder	0.0003	0.0463	CrCbGaD
Doxepin—Promethazine—HTR2A—conduct disorder	0.000299	0.0462	CrCbGaD
Doxepin—Amitriptyline—SLC6A4—conduct disorder	0.000298	0.046	CrCbGaD
Doxepin—CYP2D6—brain—conduct disorder	0.000287	0.00963	CbGeAlD
Doxepin—Desipramine—HTR2A—conduct disorder	0.000272	0.042	CrCbGaD
Doxepin—Promazine—HTR2A—conduct disorder	0.000263	0.0407	CrCbGaD
Doxepin—Imipramine—HTR2A—conduct disorder	0.00023	0.0356	CrCbGaD
Doxepin—Amitriptyline—HTR2A—conduct disorder	0.000229	0.0354	CrCbGaD
Doxepin—ABCB1—brain—conduct disorder	0.000207	0.00693	CbGeAlD
Doxepin—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	8.08e-05	0.000652	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—CGA—conduct disorder	8.07e-05	0.000651	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—CGA—conduct disorder	7.99e-05	0.000645	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—CGA—conduct disorder	7.97e-05	0.000643	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—WASF1—conduct disorder	7.86e-05	0.000634	CbGpPWpGaD
Doxepin—HTR6—GPCR downstream signaling—DRD4—conduct disorder	7.85e-05	0.000633	CbGpPWpGaD
Doxepin—HRH4—Signaling by GPCR—HTR2A—conduct disorder	7.82e-05	0.000631	CbGpPWpGaD
Doxepin—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.73e-05	0.000624	CbGpPWpGaD
Doxepin—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	7.7e-05	0.000621	CbGpPWpGaD
Doxepin—CYP1A2—Biological oxidations—COMT—conduct disorder	7.62e-05	0.000615	CbGpPWpGaD
Doxepin—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.59e-05	0.000613	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	7.59e-05	0.000612	CbGpPWpGaD
Doxepin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.57e-05	0.000611	CbGpPWpGaD
Doxepin—CYP1A2—Biological oxidations—MAOA—conduct disorder	7.57e-05	0.000611	CbGpPWpGaD
Doxepin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.54e-05	0.000609	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CGA—conduct disorder	7.52e-05	0.000606	CbGpPWpGaD
Doxepin—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	7.52e-05	0.000606	CbGpPWpGaD
Doxepin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.47e-05	0.000603	CbGpPWpGaD
Doxepin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.45e-05	0.000601	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—CGA—conduct disorder	7.4e-05	0.000597	CbGpPWpGaD
Doxepin—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	7.4e-05	0.000597	CbGpPWpGaD
Doxepin—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	7.24e-05	0.000584	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	7.16e-05	0.000578	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—DRD4—conduct disorder	7.13e-05	0.000575	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CGA—conduct disorder	7.09e-05	0.000572	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	7.09e-05	0.000572	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—DRD4—conduct disorder	7.08e-05	0.000571	CbGpPWpGaD
Doxepin—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.04e-05	0.000568	CbGpPWpGaD
Doxepin—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	6.95e-05	0.000561	CbGpPWpGaD
Doxepin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.92e-05	0.000558	CbGpPWpGaD
Doxepin—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	6.91e-05	0.000557	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CGA—conduct disorder	6.86e-05	0.000554	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CGA—conduct disorder	6.79e-05	0.000548	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—DRD4—conduct disorder	6.72e-05	0.000542	CbGpPWpGaD
Doxepin—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	6.71e-05	0.000541	CbGpPWpGaD
Doxepin—HRH2—GPCR downstream signaling—HTR2A—conduct disorder	6.68e-05	0.000539	CbGpPWpGaD
Doxepin—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	6.67e-05	0.000538	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	6.67e-05	0.000538	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—DRD4—conduct disorder	6.51e-05	0.000525	CbGpPWpGaD
Doxepin—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	6.49e-05	0.000524	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	6.48e-05	0.000523	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—CGA—conduct disorder	6.44e-05	0.00052	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—DRD4—conduct disorder	6.44e-05	0.000519	CbGpPWpGaD
Doxepin—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	6.39e-05	0.000515	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CGA—conduct disorder	6.39e-05	0.000515	CbGpPWpGaD
Doxepin—HRH2—Signaling by GPCR—HTR2A—conduct disorder	6.06e-05	0.000489	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	6.05e-05	0.000488	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—WASF1—conduct disorder	6.03e-05	0.000486	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	6.02e-05	0.000485	CbGpPWpGaD
Doxepin—DRD2—GPCR ligand binding—HTR2A—conduct disorder	5.89e-05	0.000475	CbGpPWpGaD
Doxepin—CYP3A4—Biological oxidations—COMT—conduct disorder	5.88e-05	0.000475	CbGpPWpGaD
Doxepin—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.84e-05	0.000471	CbGpPWpGaD
Doxepin—DRD2—Circadian rythm related genes—EP300—conduct disorder	5.84e-05	0.000471	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	5.81e-05	0.000469	CbGpPWpGaD
Doxepin—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.8e-05	0.000468	CbGpPWpGaD
Doxepin—HRH1—GPCR ligand binding—HTR2A—conduct disorder	5.78e-05	0.000466	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	5.78e-05	0.000466	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CGA—conduct disorder	5.77e-05	0.000465	CbGpPWpGaD
Doxepin—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	5.76e-05	0.000465	CbGpPWpGaD
Doxepin—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	5.75e-05	0.000463	CbGpPWpGaD
Doxepin—CHRM1—Circadian rythm related genes—EP300—conduct disorder	5.72e-05	0.000461	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—CGA—conduct disorder	5.7e-05	0.00046	CbGpPWpGaD
Doxepin—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	5.69e-05	0.000459	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—WASF1—conduct disorder	5.68e-05	0.000459	CbGpPWpGaD
Doxepin—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	5.67e-05	0.000458	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	5.62e-05	0.000454	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CGA—conduct disorder	5.57e-05	0.000449	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CGA—conduct disorder	5.54e-05	0.000447	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	5.53e-05	0.000446	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—WASF1—conduct disorder	5.5e-05	0.000444	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—DRD4—conduct disorder	5.49e-05	0.000443	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	5.47e-05	0.000441	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—WASF1—conduct disorder	5.44e-05	0.000439	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CGA—conduct disorder	5.39e-05	0.000434	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CGA—conduct disorder	5.3e-05	0.000428	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—DRD4—conduct disorder	5.28e-05	0.000426	CbGpPWpGaD
Doxepin—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	5.27e-05	0.000425	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.25e-05	0.000423	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—CGA—conduct disorder	5.23e-05	0.000422	CbGpPWpGaD
Doxepin—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	5.12e-05	0.000413	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—WASF1—conduct disorder	5.12e-05	0.000413	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	5.11e-05	0.000412	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—DRD4—conduct disorder	5.1e-05	0.000411	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	5.02e-05	0.000405	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	5.02e-05	0.000405	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—DRD4—conduct disorder	5.01e-05	0.000404	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	4.99e-05	0.000403	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	4.98e-05	0.000401	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	4.93e-05	0.000398	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	4.91e-05	0.000396	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CGA—conduct disorder	4.89e-05	0.000394	CbGpPWpGaD
Doxepin—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	4.83e-05	0.00039	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CGA—conduct disorder	4.81e-05	0.000388	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CGA—conduct disorder	4.8e-05	0.000387	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CGA—conduct disorder	4.78e-05	0.000386	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CGA—conduct disorder	4.77e-05	0.000385	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CGA—conduct disorder	4.72e-05	0.000381	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CGA—conduct disorder	4.71e-05	0.00038	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	4.67e-05	0.000377	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—HTR2A—conduct disorder	4.65e-05	0.000375	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.63e-05	0.000374	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	4.63e-05	0.000373	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—WASF1—conduct disorder	4.62e-05	0.000373	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—HTR2A—conduct disorder	4.62e-05	0.000373	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	4.57e-05	0.000368	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.56e-05	0.000368	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—DRD4—conduct disorder	4.55e-05	0.000367	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—DRD4—conduct disorder	4.53e-05	0.000366	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—DRD4—conduct disorder	4.52e-05	0.000365	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—DRD4—conduct disorder	4.48e-05	0.000361	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.46e-05	0.00036	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.46e-05	0.00036	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.44e-05	0.000358	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	4.39e-05	0.000354	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CGA—conduct disorder	4.37e-05	0.000353	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	4.35e-05	0.000351	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—WASF1—conduct disorder	4.32e-05	0.000348	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—WASF1—conduct disorder	4.25e-05	0.000343	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	4.24e-05	0.000342	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—DRD4—conduct disorder	4.21e-05	0.00034	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	4.2e-05	0.000339	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	4.15e-05	0.000335	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—DRD4—conduct disorder	3.97e-05	0.00032	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	3.95e-05	0.000319	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	3.93e-05	0.000317	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—WASF1—conduct disorder	3.92e-05	0.000316	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.85e-05	0.000311	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—WASF1—conduct disorder	3.84e-05	0.00031	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—DRD4—conduct disorder	3.84e-05	0.00031	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—WASF1—conduct disorder	3.83e-05	0.000309	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—WASF1—conduct disorder	3.82e-05	0.000308	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—DRD4—conduct disorder	3.8e-05	0.000307	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.79e-05	0.000306	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—WASF1—conduct disorder	3.78e-05	0.000305	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—WASF1—conduct disorder	3.77e-05	0.000304	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.77e-05	0.000304	CbGpPWpGaD
Doxepin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	3.77e-05	0.000304	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CGA—conduct disorder	3.71e-05	0.000299	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	3.67e-05	0.000296	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CGA—conduct disorder	3.62e-05	0.000292	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	3.61e-05	0.000291	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—HTR2A—conduct disorder	3.58e-05	0.000289	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—DRD4—conduct disorder	3.58e-05	0.000288	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	3.57e-05	0.000288	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.51e-05	0.000283	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.44e-05	0.000278	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.42e-05	0.000276	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CGA—conduct disorder	3.41e-05	0.000275	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CGA—conduct disorder	3.38e-05	0.000273	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	3.33e-05	0.000269	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.33e-05	0.000268	CbGpPWpGaD
Doxepin—ADRA2B—Hemostasis—EP300—conduct disorder	3.29e-05	0.000266	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.28e-05	0.000264	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.27e-05	0.000264	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	3.26e-05	0.000263	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	3.25e-05	0.000262	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—DRD4—conduct disorder	3.23e-05	0.00026	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	3.22e-05	0.000259	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	3.21e-05	0.000259	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—DRD4—conduct disorder	3.12e-05	0.000251	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.1e-05	0.00025	CbGpPWpGaD
Doxepin—ADRA2C—Hemostasis—EP300—conduct disorder	3.07e-05	0.000248	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.02e-05	0.000244	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—DRD4—conduct disorder	3.02e-05	0.000243	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.98e-05	0.00024	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—DRD4—conduct disorder	2.97e-05	0.000239	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.97e-05	0.000239	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	2.96e-05	0.000239	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	2.95e-05	0.000238	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	2.92e-05	0.000236	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.91e-05	0.000235	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—COMT—conduct disorder	2.91e-05	0.000235	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CGA—conduct disorder	2.89e-05	0.000233	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—MAOA—conduct disorder	2.89e-05	0.000233	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—HTR2A—conduct disorder	2.75e-05	0.000222	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—DRD4—conduct disorder	2.74e-05	0.000221	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.71e-05	0.000218	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.69e-05	0.000217	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—DRD4—conduct disorder	2.69e-05	0.000217	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—DRD4—conduct disorder	2.68e-05	0.000216	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—DRD4—conduct disorder	2.67e-05	0.000215	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—DRD4—conduct disorder	2.64e-05	0.000213	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.64e-05	0.000213	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HTR2A—conduct disorder	2.59e-05	0.000209	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—COMT—conduct disorder	2.57e-05	0.000208	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—MAOA—conduct disorder	2.56e-05	0.000206	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HTR2A—conduct disorder	2.51e-05	0.000202	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—EP300—conduct disorder	2.5e-05	0.000201	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HTR2A—conduct disorder	2.48e-05	0.0002	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.45e-05	0.000198	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—EP300—conduct disorder	2.45e-05	0.000197	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—COMT—conduct disorder	2.36e-05	0.00019	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—MAOA—conduct disorder	2.34e-05	0.000189	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	2.33e-05	0.000188	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CGA—conduct disorder	2.23e-05	0.00018	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	2.11e-05	0.00017	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HTR2A—conduct disorder	2.03e-05	0.000164	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.02e-05	0.000163	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.97e-05	0.000159	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.94e-05	0.000156	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—EP300—conduct disorder	1.9e-05	0.000153	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.79e-05	0.000144	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.75e-05	0.000141	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HTR2A—conduct disorder	1.75e-05	0.000141	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HTR2A—conduct disorder	1.74e-05	0.000141	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.72e-05	0.000139	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.72e-05	0.000139	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—COMT—conduct disorder	1.67e-05	0.000135	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—MAOA—conduct disorder	1.66e-05	0.000134	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—COMT—conduct disorder	1.63e-05	0.000132	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—MAOA—conduct disorder	1.62e-05	0.000131	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.61e-05	0.00013	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.6e-05	0.000129	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—COMT—conduct disorder	1.54e-05	0.000124	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—MAOA—conduct disorder	1.53e-05	0.000123	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—COMT—conduct disorder	1.53e-05	0.000123	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—MAOA—conduct disorder	1.51e-05	0.000122	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.47e-05	0.000118	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—EP300—conduct disorder	1.46e-05	0.000117	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—EP300—conduct disorder	1.37e-05	0.000111	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EP300—conduct disorder	1.33e-05	0.000107	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EP300—conduct disorder	1.31e-05	0.000106	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—COMT—conduct disorder	1.3e-05	0.000105	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MAOA—conduct disorder	1.29e-05	0.000104	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.26e-05	0.000101	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—EP300—conduct disorder	1.25e-05	0.000101	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EP300—conduct disorder	1.24e-05	9.97e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.12e-05	9e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—EP300—conduct disorder	1.1e-05	8.9e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EP300—conduct disorder	1.08e-05	8.69e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EP300—conduct disorder	1.07e-05	8.65e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EP300—conduct disorder	1.04e-05	8.41e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EP300—conduct disorder	1.03e-05	8.28e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—EP300—conduct disorder	1.01e-05	8.17e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—COMT—conduct disorder	1.01e-05	8.12e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MAOA—conduct disorder	9.99e-06	8.06e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EP300—conduct disorder	9.46e-06	7.63e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EP300—conduct disorder	9.31e-06	7.51e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EP300—conduct disorder	9.29e-06	7.49e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EP300—conduct disorder	9.26e-06	7.47e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EP300—conduct disorder	9.23e-06	7.44e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EP300—conduct disorder	9.14e-06	7.37e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EP300—conduct disorder	9.11e-06	7.35e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EP300—conduct disorder	8.47e-06	6.83e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—EP300—conduct disorder	7.17e-06	5.79e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—EP300—conduct disorder	7e-06	5.65e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—EP300—conduct disorder	6.6e-06	5.32e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—EP300—conduct disorder	6.54e-06	5.28e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—EP300—conduct disorder	5.59e-06	4.51e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—EP300—conduct disorder	4.31e-06	3.48e-05	CbGpPWpGaD
